Bo Cen to Lung Neoplasms
This is a "connection" page, showing publications Bo Cen has written about Lung Neoplasms.
Connection Strength
0.426
-
Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer. Anticancer Drugs. 2017 11; 28(10):1141-1149.
Score: 0.320
-
A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
Score: 0.106